EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
TSX:EXE - CA30224T8639 - Common Stock
12.91 CAD
-0.16 (-1.22%)
Taking everything into account, EXE scores 6 out of 10 in our fundamental rating. EXE was compared to 15 industry peers in the Health Care Providers & Services industry. While EXE has a great profitability rating, there are some minor concerns on its financial health. EXE may be a bit undervalued, certainly considering the very reasonable score on growth Finally EXE also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
EXE had positive earnings in the past year.
EXE had a positive operating cash flow in the past year.
EXE had positive earnings in each of the past 5 years.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
EXE's Return On Assets of 10.69% is amongst the best of the industry. EXE outperforms 86.67% of its industry peers.
Looking at the Return On Equity, with a value of 55.86%, EXE belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
EXE has a better Return On Invested Capital (19.22%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXE is above the industry average of 7.83%.
The last Return On Invested Capital (19.22%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| ROIC | 19.22% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
EXE has a Profit Margin of 5.51%. This is in the better half of the industry: EXE outperforms 73.33% of its industry peers.
EXE's Profit Margin has improved in the last couple of years.
EXE has a better Operating Margin (7.78%) than 73.33% of its industry peers.
In the last couple of years the Operating Margin of EXE has grown nicely.
With a Gross Margin value of 13.86%, EXE is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.78% | ||
| PM (TTM) | 5.51% | ||
| GM | 13.86% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXE is creating value.
Compared to 1 year ago, EXE has more shares outstanding
Compared to 5 years ago, EXE has less shares outstanding
The debt/assets ratio for EXE has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.81 indicates that EXE is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXE's Altman-Z score of 2.81 is fine compared to the rest of the industry. EXE outperforms 80.00% of its industry peers.
EXE has a debt to FCF ratio of 3.60. This is a good value and a sign of high solvency as EXE would need 3.60 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.60, EXE is doing good in the industry, outperforming 80.00% of the companies in the same industry.
EXE has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.79, EXE is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 3.6 | ||
| Altman-Z | 2.81 |
ROIC/WACC2.64
WACC7.27%
2.3 Liquidity
EXE has a Current Ratio of 0.85. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EXE (0.85) is comparable to the rest of the industry.
A Quick Ratio of 0.85 indicates that EXE may have some problems paying its short term obligations.
EXE's Quick ratio of 0.85 is fine compared to the rest of the industry. EXE outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.37% over the past year.
EXE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.74% yearly.
Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 8.68% in the last year.
The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)46.37%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%37.31%
Revenue 1Y (TTM)8.68%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%10.03%
3.2 Future
EXE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.71% yearly.
EXE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.19% yearly.
EPS Next Y25%
EPS Next 2Y8.65%
EPS Next 3Y5.59%
EPS Next 5Y7.71%
Revenue Next Year11.08%
Revenue Next 2Y8.8%
Revenue Next 3Y6.78%
Revenue Next 5Y5.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.88 indicates a correct valuation of EXE.
Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 86.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.14, EXE is valued a bit cheaper.
A Price/Forward Earnings ratio of 13.71 indicates a correct valuation of EXE.
Based on the Price/Forward Earnings ratio, EXE is valued cheaper than 93.33% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.80. EXE is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.88 | ||
| Fwd PE | 13.71 |
4.2 Price Multiples
86.67% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 73.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.71 | ||
| EV/EBITDA | 8.56 |
4.3 Compensation for Growth
EXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EXE may justify a higher PE ratio.
PEG (NY)0.56
PEG (5Y)0.61
EPS Next 2Y8.65%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 3.84%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.34, EXE pays a better dividend. On top of this EXE pays more dividend than 86.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, EXE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.84% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has paid a dividend for at least 10 years, which is a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EXE pays out 48.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.82%
EPS Next 2Y8.65%
EPS Next 3Y5.59%
TSX:EXE (8/26/2025, 7:00:00 PM)
12.91
-0.16 (-1.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.58%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts74.55
Price Target16.63 (28.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.84% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP48.82%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.35%
PT rev (3m)13.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)30.51%
EPS NY rev (3m)30.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.96%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.88 | ||
| Fwd PE | 13.71 | ||
| P/S | 0.72 | ||
| P/FCF | 13.71 | ||
| P/OCF | 8.23 | ||
| P/B | 7.27 | ||
| P/tB | 32.81 | ||
| EV/EBITDA | 8.56 |
EPS(TTM)0.93
EY7.2%
EPS(NY)0.94
Fwd EY7.3%
FCF(TTM)0.94
FCFY7.29%
OCF(TTM)1.57
OCFY12.15%
SpS18
BVpS1.78
TBVpS0.39
PEG (NY)0.56
PEG (5Y)0.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| ROCE | 25.43% | ||
| ROIC | 19.22% | ||
| ROICexc | 22.81% | ||
| ROICexgc | 32.51% | ||
| OM | 7.78% | ||
| PM (TTM) | 5.51% | ||
| GM | 13.86% | ||
| FCFM | 5.23% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexcg growth 3Y72.34%
ROICexcg growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 3.6 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 154.92% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 10.8 | ||
| Cash Conversion | 86.92% | ||
| Profit Quality | 94.89% | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 2.81 |
F-Score6
WACC7.27%
ROIC/WACC2.64
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.37%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%37.31%
EPS Next Y25%
EPS Next 2Y8.65%
EPS Next 3Y5.59%
EPS Next 5Y7.71%
Revenue 1Y (TTM)8.68%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%10.03%
Revenue Next Year11.08%
Revenue Next 2Y8.8%
Revenue Next 3Y6.78%
Revenue Next 5Y5.19%
EBIT growth 1Y39.21%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-5.03%
EBIT Next 3Y4.16%
EBIT Next 5Y2.27%
FCF growth 1Y179.71%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y406.79%
OCF growth 3Y31.32%
OCF growth 5Y26.02%